Proteome to pass the profit test
Protein biomarker contract research organisation Proteome Sciences (PRM:AIM) is expected to return to profit in 2013 after winning a major contract last week (19 Apr).The £130 million cap's SensiDerm product, a test for the...
25 April 2013